These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11001128)

  • 41. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection.
    Resti M; Micheli A; Moriondo M; Becciolini L; Cortimiglia M; Canessa C; Indolfi G; Bartolini E; de Martino M; Azzari C
    Clin Ther; 2009 Jun; 31(6):1266-73. PubMed ID: 19695393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia.
    Ruiz-González A; Falguera M; Nogués A; Rubio-Caballero M
    Am J Med; 1999 Apr; 106(4):385-90. PubMed ID: 10225239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community acquired pneumonia--a prospective UK study.
    Drummond P; Clark J; Wheeler J; Galloway A; Freeman R; Cant A
    Arch Dis Child; 2000 Nov; 83(5):408-12. PubMed ID: 11040149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population.
    Woolfson A; Huebner R; Wasas A; Chola S; Godfrey-Faussett P; Klugman K
    Bull World Health Organ; 1997; 75(5):453-62. PubMed ID: 9447779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A practical guide for the diagnosis and treatment of pediatric pneumonia.
    Jadavji T; Law B; Lebel MH; Kennedy WA; Gold R; Wang EE
    CMAJ; 1997 Mar; 156(5):S703-11. PubMed ID: 9068582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Community-acquired pneumonia among children: the latest evidence for an updated management.
    Nascimento-Carvalho CM
    J Pediatr (Rio J); 2020; 96 Suppl 1(Suppl 1):29-38. PubMed ID: 31518547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumonia.
    Kabra SK; Singhal T; Lodha R
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S19-23. PubMed ID: 11980455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
    J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.
    Chen CJ; Lin PY; Tsai MH; Huang CG; Tsao KC; Wong KS; Chang LY; Chiu CH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2012 Nov; 31(11):e196-201. PubMed ID: 22935863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
    File TM; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibiotic-pretreated pediatric patients.
    Deng J; Zheng Y; Zhao R; Wright PF; Stratton CW; Tang YW
    Pediatr Infect Dis J; 2009 Jan; 28(1):53-5. PubMed ID: 19034066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumonia in childhood: etiology and response to antimicrobial therapy.
    Ruuskanen O; Nohynek H; Ziegler T; Capeding R; Rikalainen H; Huovinen P; Leinonen M
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):217-23. PubMed ID: 1597197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric community-acquired pneumonia: diagnosis and management in the emergency department.
    Cooper-Sood J; Wallihan R; Naprawa J
    Pediatr Emerg Med Pract; 2019 Apr; 16(4):1-28. PubMed ID: 30908905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory infections: community-acquired pneumonia and newer microbes.
    Reynolds HY
    Lung; 1996; 174(4):207-24. PubMed ID: 8791258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a nested-PCR assay for Streptococcus pneumoniae detection in pediatric patients with community-acquired pneumonia.
    Mayoral C; Noroña M; Baroni MR; Giani R; Zalazar F
    Rev Argent Microbiol; 2005; 37(4):184-8. PubMed ID: 16502637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
    Skerrett SJ
    Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.